Results 101 to 110 of about 888 (124)

Histone and non-histone (de)acetylation impact on the blood-brain barrier. [PDF]

open access: yesFluids Barriers CNS
Melo M   +3 more
europepmc   +1 more source

Unbiased screening identifies regulators of cell-cell adhesion and treatment options in pemphigus. [PDF]

open access: yesNat Commun
Franz H   +13 more
europepmc   +1 more source

GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma. [PDF]

open access: yesLeukemia
He MY   +15 more
europepmc   +1 more source

Epigenetic Therapies for Inflammatory and Immune-Mediated Skin Diseases. [PDF]

open access: yesBiomedicines
Makridou A   +9 more
europepmc   +1 more source

The role of HDAC3 in inflammation: mechanisms and therapeutic implications. [PDF]

open access: yesFront Immunol
Watson N   +3 more
europepmc   +1 more source

RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation

International Immunopharmacology, 2021
Depression is a prevalent mental disorder. However, its pathophysiological mechanism has still remained elusive, and a limited number of effective treatments have been presented. Recent studies have shown that neuroinflammation and microglial activation are involved in the pathogenesis of depression. Histone deacetylase 3 (HDAC3) has neurotoxic effects
Gao-Hua Wang   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy